54 institutions reported holding $1.34B of HEMAB THERAPEUTI (COAG) in SEC 13F filings for 2026-06-30. Largest institutional holders: RA CAPITAL MANAGEMENT, L.P. ($286.8M), NOVO HOLDINGS A/S ($153.6M), FMR LLC ($135.8M), Capital International Investors ($132.4M), Deep Track Capital, LP ($132.3M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30